News
It’s a shot at better health that comes with a promise to help shed the pounds. Demand for drugs like Ozempic, Wegovy, Mounjaro and Zepbound continues to grow. FILE – Donna ...
1h
News-Medical.Net on MSNAmycretin delivers unprecedented weight loss in early trial for obesity treatmentBy Vijay Kumar Malesu A new trial reveals that once-weekly amycretin injections help adults shed more than 20% of their body ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for patients who have a prescription for the medication but no insurance coverage ...
Hims & Hers Health Inc.'s stock booked record losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth ...
For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...
Disgraced chef Paula Deen, 78, took time to reflect on her career by sharing a personal message with her social media followers. Georgia-born cooking ...
The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...
Skin Glow Med Spa offers services such as facials, hair removal, weight loss treatments, laser treatments and more.
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...
The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results